InvestorsHub Logo
icon url

mcd2inga

09/30/09 4:14 PM

#23089 RE: HALF FULL GLASS #23088

Half says "Why can't we stop right there."

I know it didn't say anything about Recaf positive readings in the PR, since the PR was trying to only highlight the "good".

If the Recaf came back positive, wouldn't the Dr. have liability to let the patient know and then try to find cancer somewhere?

Half, you are not answering my question.
HOW IS THE LATEST PR DIFFERENT FROM NEWS FROM SEVERAL YEARS AGO?
This PR is just repackaged information, IMO.
mcd
icon url

Gold Seeker

09/30/09 4:59 PM

#23094 RE: HALF FULL GLASS #23088

Half, you seem to think RECAF is for some reason not able to escape the "dark closet" of the medical unknowns.

It is a fact that if the medical community or the public thinks a product is worthwhile, a market will develop. That is how anything is sold. Just as Moro has stated, there is no obstacle to selling RECAF home brew in the US. Why is there not one lab willing to sign a license with Moro?

The labs in the US market a lot of home brew tests. IMO, no one wants the test. The national cancer societies don't even mention it. The medical community is silent. No one is excited about RECAF except stock pumping websites and Moro.

Sure, he presents at the ISOBM and nothing happens. He presented the results of the ELISA test last year. He had hyped that he would license the test to labs for up front, minimum sales, milestones and not one single lab signed on.

Inverness has automated Elisa machines in 5000 hospitals and clinics that have the capability of running RECAF tests RIGHT NOW. They do not have to wait and get it on any machine. It was available when Moro developed the ELISA test 16 months ago. Why no trials? Nothing...